与诺和诺德官宣合作“不敌”去年净利下滑 联邦制药盘中跌13%

澎湃新闻
25 Mar

3月25日,联邦制药国际控股有限公司(联邦制药,3933.HK)盘中跌超13%,收跌11.78%,报14.68港元/股,市值266.74亿港元。此次股价波动令不少投资者感到意外。消息面上,3月25日晚间,联邦制药官宣了与丹麦制药企业诺和诺德就一款GLP-1/GIP/GCG三靶点减肥药UBT251的独家许可协议。根据官方披露的内容,联邦制药全资附属公司联邦生物与诺和诺德达成许可协议,联邦生物将授予...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10